REGULATION OF N-ACETYLGLUCOSAMINYLTRANSFERASE-V BY PROTEIN-KINASES

被引:20
|
作者
JU, TZ [1 ]
CHEN, HL [1 ]
GU, JX [1 ]
QIN, H [1 ]
机构
[1] SHANGHAI MED UNIV,DEPT BIOCHEM,GLYCOCONJUGATE RES LAB,SHANGHAI 200032,PEOPLES R CHINA
关键词
N-ACETYLGLUCOSAMINYLTRANSFERASE V; HEPATOCARCINOMA CELLS; PROTEIN KINASE; PHOSPHORYLATION DEPHOSPHORYLATION;
D O I
10.1007/BF00731237
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When 7721 human hepatocarcinoma cells were treated with 100 nM phorbol-12-myristate-13-acetate (PMA), the activity of N-acetylglucosaminyltransferase V(GnT-V) in the cells varied in accordance with the activity of membranous protein kinase C (PKC), but not with that of cytosolic PKC. Quercetin, a non-specific inhibitor of Ser/Thr protein kinase, and D-sphingosine and staurosporine, two specific inhibitors of PKC, blocked the activation of membranous PKC and GnT-V by PMA. Among the three inhibitors, quercetin was least effective. The inhibitory rates of quercetin and staurosporine toward membranous PKC and GnTV were proportional to the concentrations of the two inhibitors. The activities of GnTV and membranous protein kinase A (PKA) were also induced in parallel by dibutyryl cAMP (db-cAMP) and this induction was blocked by a specific PKA inhibitor. When cell free preparations of 7721 cells and human kidney were treated with alkaline phosphatase (ALP) to remove the phosphate groups, the GnTV activities were decreased. These results suggest that GnTV may be activated by membranous PKC or PKA, indirectly or directly, via phosphorylation of Ser/Thr residues.
引用
收藏
页码:767 / 772
页数:6
相关论文
共 50 条
  • [1] Recognition of glycan and protein substrates by N-acetylglucosaminyltransferase-V
    Hirata, Tetsuya
    Nagae, Masamichi
    Osuka, Reina F.
    Mishra, Sushil K.
    Yamada, Mayumi
    Kizuka, Yasuhiko
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2020, 1864 (12):
  • [2] SYNTHESIS OF INHIBITOR FOR N-ACETYLGLUCOSAMINYLTRANSFERASE-V
    KAJIMOTO, T
    TAKAOKA, Y
    WONG, CH
    GLYCOCONJUGATE JOURNAL, 1993, 10 (04) : 228 - 228
  • [3] REGULATION OF N-ACETYLGLUCOSAMINYLTRANSFERASE-V (GLCNAC-T-V) BY ONCOGENE EXPRESSION
    PIERCE, M
    BUCKHAULTS, P
    SHOREIBAH, M
    PERNG, GS
    FREGIEN, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 260 - 260
  • [4] RECOGNITION OF OLIGOSACCHARIDE SUBSTRATES BY N-ACETYLGLUCOSAMINYLTRANSFERASE-V
    SRIVASTAVA, OP
    HINDSGAUL, O
    SHOREIBAH, M
    PIERCE, M
    CARBOHYDRATE RESEARCH, 1988, 179 : 137 - 161
  • [5] ORGANIZATION OF THE HUMAN N-ACETYLGLUCOSAMINYLTRANSFERASE-V GENE
    SAITO, H
    GU, JG
    NISHIKAWA, A
    IHARA, Y
    FUJII, J
    KOHGO, Y
    TANIGUCHI, N
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 233 (01): : 18 - 26
  • [6] Cryostorage of unstable N-acetylglucosaminyltransferase-V by synthetic zwitterions
    Hirata, Tetsuya
    Takekiyo, Takahiro
    Yoshimura, Yukihiro
    Tokoro, Yuko
    Ishizaki, Takeru
    Kizuka, Yasuhiko
    Kuroda, Kosuke
    RSC ADVANCES, 2022, 12 (19) : 11628 - 11631
  • [7] New synthetic trisaccharide inhibitors for N-acetylglucosaminyltransferase-V
    Lu, PP
    Hindsgaul, O
    Compston, CA
    Palcic, MM
    BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (11) : 2011 - 2022
  • [8] EXPRESSION OF N-ACETYLGLUCOSAMINYLTRANSFERASE-III AND N-ACETYLGLUCOSAMINYLTRANSFERASE-V IN LEC RATS DURING HEPATOCARCINOGENESIS
    MIYOSHI, E
    HAYASHI, N
    FUSAMOTO, H
    KAMADA, T
    NISHIKAWA, A
    TANIGUCHI, N
    HEPATOLOGY, 1994, 19 (04) : I103 - I103
  • [9] AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR N-ACETYLGLUCOSAMINYLTRANSFERASE-V
    CRAWLEY, SC
    HINDSGAUL, O
    ALTON, G
    PIERCE, M
    PALCIC, MM
    ANALYTICAL BIOCHEMISTRY, 1990, 185 (01) : 112 - 117
  • [10] Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V
    Nagae, Masamichi
    Kizuka, Yasuhiko
    Mihara, Emiko
    Kitago, Yu
    Hanashima, Shinya
    Ito, Yukishige
    Takagi, Junichi
    Taniguchi, Naoyuki
    Yamaguchi, Yoshiki
    NATURE COMMUNICATIONS, 2018, 9